KDM1A and Kabuki syndrome: Recent studies have shown that upregulation of H3K4 methylation by oral KDM1A-specific inhibitors can rescues the defects of adult neurogenesis in the mouse models of Kabuki syndrome (KS), significantly improve the visuospatial learning and memory defect (Zhang et al., 2021).